David Maxwell Barrett

22.9k citations
141 papers · 18.6k · 8 hit papers · h-index 55

Impact in

  • Oncology top 0.05%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 66
    • Urinary Bladder and Prostate Research 16
    • Urological Disorders and Treatments 10

David Maxwell Barrett

140 papers receiving 17.8k citations

David Maxwell Barrett's Hit Papers

Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial 2025 · 44 citations
440+4+9Years since publication10002.0k3.0k4.0k

Peers

David Maxwell Barrett
Comparison fields: 5 of 146
  • Oncology 12.6k
  • Immunology 4.5k
  • Hematology 1.7k
  • Genetics 3.2k
  • Urology 665
Replace Andrew M. Davidoff with:
Andrew M. Davidoff United States
Paul L. Martin United States
Russell S. Taichman United States
Adriana Cristina Balduzzi Italy
Peter Bader Germany
Robert S. Negrin United States
Peter A. McSweeney United States
Antonio R. Pérez‐Atayde United States
Peiman Hematti United States
Dominique Bron Belgium
David Maxwell Barrett relative to Andrew M. Davidoff United States Andrew M. Davidoff's profile →
Citations per field
00.5×2×3×4×4.8×
Andrew M. Davidoff · 1×
Citations per year

Countries citing papers authored by David Maxwell Barrett

Since Specialization
Citations

This map shows the geographic impact of David Maxwell Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Maxwell Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Maxwell Barrett more than expected).

Fields of papers citing papers by David Maxwell Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Maxwell Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Maxwell Barrett. The network helps show where David Maxwell Barrett may publish in the future.

Co-authors

The 25 scholars most cited alongside David Maxwell Barrett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Maxwell Barrett Line = papers co-authored together David Maxwell Barrett links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 141 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Hit paper breakdown →
20144551
2
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Hit paper breakdown →
20132979
3
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia
Hit paper breakdown →
2016941
4
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Hit paper breakdown →
2014636
5 1994566
6
Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy
Hit paper breakdown →
2013545
7
Anti-CD22–chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
Hit paper breakdown →
2012492
8 2016396
9 2020314
10 2013303
11
Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results
Hit paper breakdown →
2024263
12 2019260
13 2012236
14 2017234
15 2019210
16 2018187
17 2021172
18 2021163
19 2015152
20 1996149

About David Maxwell Barrett

David Maxwell Barrett is a scholar working on Oncology, Urology, Immunology, Hematology and Public Health, Environmental and Occupational Health, having authored 141 papers that have together received 18.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (66 papers), Immune Cell Function and Interaction (26 papers), Acute Lymphoblastic Leukemia research (20 papers), Virus-based gene therapy research (19 papers), Urinary Bladder and Prostate Research (16 papers), Prostate Cancer Diagnosis and Treatment (14 papers), Urological Disorders and Treatments (10 papers) and Pelvic floor disorders treatments (10 papers). The work is most often cited by research in Oncology (12.6k citations), Immunology (4.5k citations), Hematology (1.7k citations), Genetics (3.2k citations) and Urology (665 citations). David Maxwell Barrett has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Stephan A. Grupp, David T. Teachey, Carl H. June, David L. Porter, Shannon L. Maude, Susan R. Rheingold, Richard Aplenc, Bruce L. Levine, Anne Chew and Jan Joseph Melenhorst. Their work appears in journals such as Blood, The Journal of Urology, Urology, Transplantation and Cellular Therapy and Cytotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact